These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial. Preti RC; Ramirez LM; Monteiro ML; Carra MK; Pelayes DE; Takahashi WY Br J Ophthalmol; 2013 Jul; 97(7):885-9. PubMed ID: 23686001 [TBL] [Abstract][Full Text] [Related]
29. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Messias A; Ramos Filho JA; Messias K; Almeida FP; Costa RA; Scott IU; Gekeler F; Jorge R Doc Ophthalmol; 2012 Jun; 124(3):225-36. PubMed ID: 22457045 [TBL] [Abstract][Full Text] [Related]
30. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure. Boynton GE; Stem MS; Kwark L; Jackson GR; Farsiu S; Gardner TW Ophthalmology; 2015 May; 122(5):957-67. PubMed ID: 25601533 [TBL] [Abstract][Full Text] [Related]
31. Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: a randomized study in 44 eyes with a long follow-up time. Bandello F; Brancato R; Trabucchi G; Lattanzio R; Malegori A Graefes Arch Clin Exp Ophthalmol; 1993 Sep; 231(9):491-4. PubMed ID: 8224951 [TBL] [Abstract][Full Text] [Related]
32. Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial. Hutton DW; Stein JD; Glassman AR; Bressler NM; Jampol LM; Sun JK; JAMA Ophthalmol; 2019 Dec; 137(12):1424-1432. PubMed ID: 31647496 [TBL] [Abstract][Full Text] [Related]
33. Electroretinogram evaluation for the treatment of proliferative diabetic retinopathy by short-pulse pattern scanning laser panretinal photocoagulation. Ye H; Yu M; Lu L; Jin C; Luo G Lasers Med Sci; 2018 Jul; 33(5):1095-1102. PubMed ID: 29542045 [TBL] [Abstract][Full Text] [Related]
34. Changes in retinal venular oxygen saturation predict activity of proliferative diabetic retinopathy 3 months after panretinal photocoagulation. Torp TL; Kawasaki R; Wong TY; Peto T; Grauslund J Br J Ophthalmol; 2018 Mar; 102(3):383-387. PubMed ID: 28765148 [TBL] [Abstract][Full Text] [Related]
35. Subclassification of preproliferative diabetic retinopathy and glycemic control: relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy. Sato Y; Lee Z; Hayashi Y Jpn J Ophthalmol; 2001; 45(5):523-7. PubMed ID: 11583677 [TBL] [Abstract][Full Text] [Related]
39. [Therapeutic effect of argon green laser for diabetic retinopathy]. Tang LP; Feng HY Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1452-4. PubMed ID: 15604086 [TBL] [Abstract][Full Text] [Related]
40. Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation. Messias K; Barroso RM; Jorge R; Messias A Doc Ophthalmol; 2018 Oct; 137(2):121-129. PubMed ID: 30209775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]